MediPharm Labs Announces Board Shake-Up
The company, based in Barrie, Ontario, revealed that Pat McCutcheon, Warren Everitt and Keith Strachan have resigned from the board.
The move represents the next step in MediPharm's transformation to an operating pharmaceutical cannabis manufacturing company, maturing beyond the founder-lead phase of the business.
"I would like to thank Pat, Warren, and Keith for their vision and execution as founders of MediPharm Labs," Chris Taves, the board's chairman said. "Accomplishments like the first non-cultivation processing license in Canada, a fully functional GMP facility in Australia, and the only domestic GMP license in North America for the extraction of natural cannabinoids, could not have been achieved without the vision and foresight of these leaders."
With MediPharm Labs' strong cash position, the board will oversee the company's execution of its global pharmaceutical cannabinoid strategy.
The company's board now currently has six members, including:
- Chris Taves, Chairman
- Bryan Howcroft, CEO
- Chris Halyk
- Shelley Martin
- Miriam McDonald
- Dr. Paul Tam
Medical Marijuana’s Kannaway Hires José Miguel Gutiérrez Vázquez
c brings over 15 years of experience in marketing, advertising, and sales as well as extensive knowledge in nutrition and wellness, having spent the past decade forming partnerships, launching …